清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Peptide–drug conjugate-based novel molecular drug delivery system in cancer

药品 药物输送 结合 药理学 肽 化学 医学 靶向给药 生物化学 数学 数学分析 有机化学
作者
Yishen Zhu,Kexing Tang,Jiayi Lv
出处
期刊:Trends in Pharmacological Sciences [Elsevier BV]
卷期号:42 (10): 857-869 被引量:142
标识
DOI:10.1016/j.tips.2021.07.001
摘要

A single peptide–drug conjugate molecule achieves multiple biological functions, which is proposed as a novel drug delivery system, the molecular drug delivery system. Recently, peptide–drug conjugates have been introduced as potential diagnostics and anticancer drugs in the clinic. Aminopeptidase N, integrins, the somatostatin receptor, and several other receptors are major molecular targeting receptors for current peptide–drug conjugate-based molecular drug delivery systems. Solving the problem of oral administration will greatly promote the development of peptide–drug conjugate molecular drug delivery systems. Drug delivery systems are generally believed to comprise drugs and excipients. A peptide–drug conjugate is a single molecule that can simultaneously play multiple roles in a drug delivery system, such as in vivo drug distribution, targeted release, and bioactivity functions. This molecule can be regarded as an integrated drug delivery system, so it is called a molecular drug delivery system. In the context of cancer therapy, a peptide–drug conjugate comprises a tumor-targeting peptide, a payload, and a linker. Tumor-targeting peptides specifically identify membrane receptors on tumor cells, improve drug-targeted therapeutic effects, and reduce toxic and side effects. Payloads with bioactive functions connect to tumor-targeting peptides through linkers. In this review, we explored ongoing clinical work on peptide–drug conjugates targeting various receptors. We discuss the binding mechanisms of tumor-targeting peptides and related receptors, as well as the limiting factors for peptide–drug conjugate-based molecular drug delivery systems. Drug delivery systems are generally believed to comprise drugs and excipients. A peptide–drug conjugate is a single molecule that can simultaneously play multiple roles in a drug delivery system, such as in vivo drug distribution, targeted release, and bioactivity functions. This molecule can be regarded as an integrated drug delivery system, so it is called a molecular drug delivery system. In the context of cancer therapy, a peptide–drug conjugate comprises a tumor-targeting peptide, a payload, and a linker. Tumor-targeting peptides specifically identify membrane receptors on tumor cells, improve drug-targeted therapeutic effects, and reduce toxic and side effects. Payloads with bioactive functions connect to tumor-targeting peptides through linkers. In this review, we explored ongoing clinical work on peptide–drug conjugates targeting various receptors. We discuss the binding mechanisms of tumor-targeting peptides and related receptors, as well as the limiting factors for peptide–drug conjugate-based molecular drug delivery systems. a chemotherapy medication used to treat chronic lymphocytic leukemia (CLL), Hodgkin lymphoma, and non-Hodgkin lymphoma. the rate of application of a dose, which means quantity (in units of energy/mass) in the fields of nutrition, and medicine, although in common and imprecise usage the words are sometimes used synonymously. formulation technologies for transporting active pharmaceutical ingredients in the body as needed to safely achieve the desired therapeutic or diagnostic effects. engineered technologies that use nanoscale particles for the targeted delivery and controlled release of active pharmaceutical ingredients. gives companies researching cures for rare diseases a 7-year window of tax reductions and the exclusive right to develop a cure for a specific condition. active pharmaceutical ingredients, which can be effectively used for diagnosis/treatment in patients. a small, protein-like chain designed to mimic a peptide. tomography in which a computer-generated image of a biological activity in the body is produced through the detection of gamma-rays that are emitted when introduced radionuclides decay and release positrons. a peptide hormone that regulates the endocrine system and affects neurotransmission and cell proliferation via interaction with G protein-coupled somatostatin receptors and inhibition of the release of numerous secondary hormones. a short peptide, typically in an α-helical conformation, that is constrained by a synthetic brace as a staple.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
kk完成签到,获得积分10
26秒前
luoqin完成签到 ,获得积分10
31秒前
姚芭蕉完成签到 ,获得积分0
39秒前
my完成签到 ,获得积分10
42秒前
朴实惜寒完成签到,获得积分10
44秒前
47秒前
朴实雨竹完成签到,获得积分10
53秒前
阿巴完成签到,获得积分10
1分钟前
8D完成签到 ,获得积分10
1分钟前
无限的画板完成签到 ,获得积分10
1分钟前
1分钟前
我爱木棉完成签到 ,获得积分10
1分钟前
颜三路吴彦祖完成签到 ,获得积分10
1分钟前
怕孤单的翠琴完成签到 ,获得积分10
2分钟前
新人钱粮完成签到 ,获得积分10
2分钟前
呆橘完成签到 ,获得积分10
2分钟前
1997SD完成签到,获得积分10
2分钟前
顾矜的应助被竹捷采纳,获得10
2分钟前
刘瑶龙完成签到 ,获得积分10
2分钟前
默默问芙完成签到,获得积分10
2分钟前
可乐的应助被Lijunjie采纳,获得10
2分钟前
Lucky完成签到 ,获得积分10
2分钟前
Lijunjie完成签到,获得积分10
2分钟前
2分钟前
淡然的冬瓜完成签到,获得积分10
2分钟前
ChandlerZB完成签到,获得积分10
2分钟前
changfox完成签到,获得积分10
2分钟前
竹捷发布了新的文献求助10
2分钟前
Zoe完成签到,获得积分10
2分钟前
温柔樱桃完成签到 ,获得积分10
3分钟前
3分钟前
3分钟前
面汤完成签到 ,获得积分10
3分钟前
hover发布了新的文献求助10
3分钟前
cczzhh发布了新的文献求助10
3分钟前
负责的紫安完成签到 ,获得积分10
3分钟前
GankhuyagJavzan完成签到,获得积分10
3分钟前
hover完成签到,获得积分10
3分钟前
3分钟前
KKK的科研完成签到 ,获得积分10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8195261
求助须知:如何正确求助?哪些是违规求助? 9580992
关于积分的说明 21873160
捐赠科研通 7795344
什么是DOI,文献DOI怎么找? 3437973
关于科研通互助平台的介绍 2561284
邀请新用户注册赠送积分活动 2484713